Journal of Clinical Endocrinology & Metabolism, Vol 70, 485-490, Copyright © 1990 by Endocrine Society

ARTICLES

Defective glucocorticoid regulation of proopiomelanocortin gene expression and peptide secretion in a small cell lung cancer cell line

AJ Clark, MF Stewart, PM Lavender, W Farrell, SR Crosby, LH Rees and A White
Department of Endocrinology, St. Bartholomew's Hospital Medical College, London, Great Britain.

A human small cell lung cancer cell line (COR L103) that actively expresses the proopiomelanocortin (POMC) gene has been used as a model of extrapituitary ACTH-secreting tumors to investigate the phenomenon of resistence of ACTH production to glucocorticoids. After both short term (24 h) and long term (10 days) exposure to hydrocortisone at concentrations of 500 and 1000 nM, the accumulation of intracellular POMC mRNA, ACTH, and ACTH precursor peptides in the culture medium was not suppressed. These finding contrast with those in the pituitary corticotroph cell line AtT20, in which POMC mRNA, ACTH, and ACTH precursors were suppressed under the same conditions. Two other genes that are regulated by glucocorticoids in other cell types, the tyrosine amino transferase gene and the glucocorticoid receptor gene, were expressed in COR L103 cells. However, neither gene appeared to be regulated by hydrocortisone in this small cell lung cancer cell line. Further studies demonstrated that glucocorticoid receptor binding could be detected in the nucleus and cytoplasm, with a Kd of 5 X 10(-9) M. It is concluded that nonsuppression of POMC by glucocorticoids is probably part of a more global defect of glucocorticoid signaling in these cells, but that this defect lies distal to steroid binding in the nucleus.

This article has been cited by other articles:

				H. S WILLENBERG, J. FELDKAMP, R. LEHMANN, M. SCHOTT, P. E GORETZKI, and W. A SCHERBAUM A case of catecholamine and glucocorticoid excess syndrome due to a corticotropin-secreting paraganglioma. Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 52 - 58. [Abstract] [Full Text] [PDF]

				C E Waters, A Stevens, A White, and D W Ray Analysis of co-factor function in a glucocorticoid-resistant small cell carcinoma cell line J. Endocrinol., November 1, 2004; 183(2): 375 - 383. [Abstract] [Full Text] [PDF]

				A. White, D. W. Ray, A. Talbot, P. Abraham, A. J. Thody, and J. S. Bevan Cushing's Syndrome Due to Phaeochromocytoma Secreting the Precursors of Adrenocorticotropin J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4771 - 4775. [Abstract] [Full Text]

				D. W. RAY, S.-G. REN, and S. MELMED Leukemia Inhibitory Factor Regulates Proopiomelanocortin Transcription Ann. N.Y. Acad. Sci., May 1, 1998; 840(1): 162 - 173. [Abstract] [Full Text] [PDF]

				P. A. Iredale and R. S. Duman Glucocorticoid Regulation of Corticotropin-Releasing Factor1 Receptor Expression in Pituitary-Derived AtT-20 Cells Mol. Pharmacol., May 1, 1997; 51(5): 794 - 799. [Abstract] [Full Text]

				D. N. Orth Cushing's Syndrome N. Engl. J. Med., March 23, 1995; 332(12): 791 - 803. [Full Text] [PDF]